ArticleFrontiers in oncology2024

Carboplatin, paclitaxel, and pembrolizumab followed by pembrolizumab maintenance for primary treatment of incompletely resected epithelial ovarian cancer.

Denise Uyar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.